Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

May 18, 2018 updated by: University of Colorado, Denver

Effects of Sprinkles With and Without Iron on Zinc Absorption From Local Foods in Kenyan Toddlers, Including the Gut Microbiome

The investigators propose to study the effects of increased iron intake by home fortification of complementary foods on the gastrointestinal microbial development, inflammatory responses, and zinc (Zn) absorption. The proposed subjects are 9 month olds living in a malaria endemic area of rural Kenya who are randomized at 6 months of age to one of three fortificant groups: 1) Sprinkles™ with 12mg Iron(Fe)/day + other micronutrients, including 5mg/d Zn (test); Sprinkles™ with 0 mg/d Fe + other micronutrients, including 5mg/d Zn (control); Sprinkles™ with no micronutrients (placebo). The investigators hypothesize that the microbiome will be significantly different in the three groups and that Zn absorption and status, in addition to immune and oxidant status will be improved in the non-Fe fortified groups when compared to the Fe-fortified group.

Study Overview

Detailed Description

Specific aims include exploration of possible mechanisms of adverse events that have been observed in iron supplementation trials in infants in malaria endemic regions by:

  1. Characterizing the impact of enteral iron administration on the evolution of the intestinal microbiome in infants from 6 to 9 months of age.
  2. Characterizing iron administration-associated inflammatory responses and correlate these with changes in the intestinal microbiome in infants from 6 to 9 months of age. Specifically, changes in the microbiome will be correlated with biomarkers reflecting:

    1. Intestinal inflammation;
    2. Systemic inflammation, bacterial translocation, and oxidant stress;
    3. Iron status and homeostasis
  3. Quantify to what degree Fe interferes with Zn absorption (TAZ) and how it affects the size of the infant's exchangeable zinc pool (EZP).

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Eldoret, Kenya
        • Moi University
    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 10 months (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Term infant
  • Birthweight > 2500 g
  • Healthy with no apparent congenital anomalies
  • Up-to-date with vaccinations
  • Hb >10 g/dL
  • Breastfeeding with intent to continue for duration of study
  • Negative blood slide for malaria
  • Written informed consent

Exclusion Criteria:

  • Acute malnutrition
  • Current or anticipated used of infant formula or other fortified products
  • Current or planned use of iron (or zinc) supplements
  • Previous hospitalization for malaria within the last four weeks
  • Persistent diarrhea

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Micronutrient Powder (MNP) + Zn/Fe
Micronutrient Powder with 5 mg Zn and 12 mg Fe
Micronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age
Active Comparator: MNP + Zn
Micronutrient Powder with 5 mg Zn
Micronutrient powder with 5 mg Zn provided daily from 6-9 months of age
Placebo Comparator: Control
Placebo sachets without micronutrients
Placebo powder without micronutrients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in GI microbiome
Time Frame: 6 and 9 months of age
Identify and quantify the phylogenic distribution of bacterial genera in the infants from 6 to 9 months in prevalence or abundance with iron supplementation at baseline, mid-point and 9 months.
6 and 9 months of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Biomarkers of intestinal and system inflammation
Time Frame: 6 and 9 months of age
Compare mean baseline and 9 month values biomarkers of intestinal and systemic inflammation and look at differences among the 3 groups.
6 and 9 months of age
Absorption of Zn
Time Frame: 9 months of age
Determine the effects of increased iron intake on zinc absorption from micronutrient powder added to local complementary foods of Kenyan toddlers in a malaria-endemic area.
9 months of age
Size of exchangeable Zn pool
Time Frame: 9 months of age
Determine the effect of increase iron intake on size of exchangeable Zn pool (EZP) after 3 months of home fortification with micronutrient powder in maize-based diets in rural Kenyan infants.
9 months of age
Change in Biomarkers of bacterial translocation
Time Frame: 6 and 9 mo of age
To compare biomarkers of bacterial translocation among the 3 groups and look at longitudinal differences between 6 and 9 mo of age.
6 and 9 mo of age
Change in Biomarkers of oxidative stress
Time Frame: 6 and 9 mo of age
Compare biomarkers of oxidative stress among the 3 groups and look at longitudinal differences at 6 and 9 mo of age.
6 and 9 mo of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nancy F Krebs, MD, University of Colorado, Denver
  • Study Director: Fabian Esamai, MD, Moi Univeristy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

March 28, 2014

First Submitted That Met QC Criteria

March 28, 2014

First Posted (Estimate)

April 2, 2014

Study Record Updates

Last Update Posted (Actual)

May 21, 2018

Last Update Submitted That Met QC Criteria

May 18, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 11-0227
  • 16933 (Other Grant/Funding Number: IAEA)
  • K24DK083772 (U.S. NIH Grant/Contract)
  • 15827 (Other Grant/Funding Number: IAEA)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Micronutrient Deficiencies

Clinical Trials on MNP + Zn/Fe

3
Subscribe